0001382963-20-000008.txt : 20200117 0001382963-20-000008.hdr.sgml : 20200117 20200117180109 ACCESSION NUMBER: 0001382963-20-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200115 FILED AS OF DATE: 20200117 DATE AS OF CHANGE: 20200117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Doyle Noah CENTRAL INDEX KEY: 0001631673 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37428 FILM NUMBER: 20534587 MAIL ADDRESS: STREET 1: C/O RITTER PHARMACEUTICALS INC. STREET 2: 1801 CENTURY PARK EAST, SUITE 1820 CITY: LOS ANGELES STATE: CA ZIP: 90096 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RITTER PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001460702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263474527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1880 CENTURY PARK EAST, SUITE 1000 CITY: LOS ANGELES STATE: CA ZIP: 90067 BUSINESS PHONE: 310-203-1000 MAIL ADDRESS: STREET 1: 1880 CENTURY PARK EAST, SUITE 1000 CITY: LOS ANGELES STATE: CA ZIP: 90067 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-01-15 0001460702 RITTER PHARMACEUTICALS INC RTTR 0001631673 Doyle Noah RITTER PHARMACEUTICALS, INC. 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES, CA 90067 1 0 1 0 Non-qualified Stock Option (right to buy) .23 2020-01-15 4 A 0 12000 0 A 2030-01-15 Common Stock 12000 12000 D The option vests in twelve (12) equal monthly installments beginning on February 15, 2020 with the balance vesting on the 15th day of each calendar month thereafter until vested in full. /s/Andrew J. Ritter, attorney-in-fact 2020-01-17